These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 11496733

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Oxidative stress, antioxidant status and lipid profile in ischemic heart disease patients from western region of Nepal.
    Maharjan BR, Jha JC, Adhikari D, Akila, Risal S, Alurkar VM, Singh PP.
    Nepal Med Coll J; 2008 Mar; 10(1):20-4. PubMed ID: 18700625
    [Abstract] [Full Text] [Related]

  • 24. [HindIII DNA-polymorphism of lipoprotein lipase gene in elderly patients with ischemic heart disease].
    Malygina NA, Kostomarova IV, Deriagin GV, Serova LD.
    Ter Arkh; 2002 Mar; 74(2):64-6. PubMed ID: 11899831
    [Abstract] [Full Text] [Related]

  • 25. Correlation between oxidized low-density lipoprotein and other factors in patients on peritoneal dialysis.
    Futatsuyama M, Oiwa T, Komatsu Y.
    Adv Perit Dial; 2002 Mar; 18():192-4. PubMed ID: 12402617
    [Abstract] [Full Text] [Related]

  • 26. Aminothiol redox alterations in patients with chronic heart failure of ischaemic or non-ischaemic origin.
    Campolo J, Caruso R, De Maria R, Parolini M, Oliva F, Roubina E, Cighetti G, Frigerio M, Vitali E, Parodi O.
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1024-8. PubMed ID: 18163014
    [Abstract] [Full Text] [Related]

  • 27. Association between the PPARalpha L162V polymorphism, plasma lipoprotein levels, and atherosclerotic disease in patients with diabetes mellitus type 2 and in nondiabetic controls.
    Gouni-Berthold I, Giannakidou E, Müller-Wieland D, Faust M, Kotzka J, Berthold HK, Krone W.
    Am Heart J; 2004 Jun; 147(6):1117-24. PubMed ID: 15199365
    [Abstract] [Full Text] [Related]

  • 28. [Risk factors of ischemic heart disease and lipid metabolism in cardiorespiratory diseases].
    Avdeeva EV, Koval'skaia EA, Vostrikova OG.
    Klin Med (Mosk); 2000 Jun; 78(3):25-8. PubMed ID: 10790960
    [Abstract] [Full Text] [Related]

  • 29. [Pumpan in the treatment of ischemic heart disease associated with arterial hypertension].
    Golikov AP, Babaian IS.
    Ter Arkh; 2001 Jun; 73(10):68-9. PubMed ID: 11763522
    [Abstract] [Full Text] [Related]

  • 30. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up.
    Almdal T, Scharling H, Jensen JS, Vestergaard H.
    Arch Intern Med; 2004 Jul 12; 164(13):1422-6. PubMed ID: 15249351
    [Abstract] [Full Text] [Related]

  • 31. Dyslipoproteinemia and diabetes.
    Orchard TJ.
    Endocrinol Metab Clin North Am; 1990 Jun 12; 19(2):361-80. PubMed ID: 2192878
    [Abstract] [Full Text] [Related]

  • 32. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C, Olsson AG.
    Int J Clin Pract Suppl; 2002 Jul 12; (130):27-32. PubMed ID: 12296606
    [Abstract] [Full Text] [Related]

  • 33. [Study of serum levels of homocystein, lipids and their peroxidation products in patients with coronary heart disease].
    Belaia OL, Fedorova NV.
    Klin Med (Mosk); 2005 Jul 12; 83(11):30-3. PubMed ID: 16404936
    [Abstract] [Full Text] [Related]

  • 34. [Epidemiologic aspects of ischemic heart diseases in diabetic women].
    Orosz I.
    Orv Hetil; 1999 Jun 13; 140(24):1357-60. PubMed ID: 10439637
    [Abstract] [Full Text] [Related]

  • 35. [Features of silent myocardial ischemia in male patients with coronary disease].
    Dolbikova NV, Mazurov VI, Petrovskiĭ VI, Mironova OA.
    Klin Med (Mosk); 2003 Jun 13; 81(2):51-3. PubMed ID: 12685237
    [Abstract] [Full Text] [Related]

  • 36. [Lisinopril-induced changes in antioxidant defense in patients with acute coronary syndrome and concomitant diabetes mellitus type 2].
    Kratnov AE, Popov SA, Kratnov AA, Dem'iankova IuO.
    Ter Arkh; 2005 Jun 13; 77(12):14-8. PubMed ID: 16514812
    [Abstract] [Full Text] [Related]

  • 37. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.
    Wiviott SD, Braunwald E, Angiolillo DJ, Meisel S, Dalby AJ, Verheugt FW, Goodman SG, Corbalan R, Purdy DA, Murphy SA, McCabe CH, Antman EM, TRITON-TIMI 38 Investigators.
    Circulation; 2008 Oct 14; 118(16):1626-36. PubMed ID: 18757948
    [Abstract] [Full Text] [Related]

  • 38. Ischaemic heart disease, Type 1 diabetes, and cow milk A1 beta-casein.
    Laugesen M, Elliott R.
    N Z Med J; 2003 Jan 24; 116(1168):U295. PubMed ID: 12601419
    [Abstract] [Full Text] [Related]

  • 39. [The mechanisms of the intensification of free radical processes in patients with IHD-stenocardia in relation to its severity].
    Kogan AKh, Ershov VI, Sokolova IIa.
    Ter Arkh; 1994 Jan 24; 66(4):32-6. PubMed ID: 8016725
    [Abstract] [Full Text] [Related]

  • 40. [The role of the system of hemostasis in the development of vascular lesions in diabetes mellitus].
    Lapotnikov VA, Moiseev SI.
    Ter Arkh; 1988 Jan 24; 60(9):31-5. PubMed ID: 3217876
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.